Unnati Pharmax

Levaquin (Levofloxacin) – Levolkem Tablets
Composition: Levofloxacin Tablets
International Trade Name: Levaquin®

Levolkem Tablets are high-quality Levofloxacin tablets, a therapeutic equivalent of the internationally recognized fluoroquinolone antibiotic marketed under the brand name Levaquin®. Manufactured in WHO-GMP certified facilities, Levolkem is supplied by reliable pharmaceutical manufacturers and exporters from India to support global antibacterial and anti-infective treatment programs.

Levofloxacin is a broad-spectrum fluoroquinolone antibiotic that works by inhibiting bacterial DNA gyrase and topoisomerase IV, leading to rapid bactericidal action against a wide range of Gram-positive and Gram-negative pathogens. Levolkem Tablets are primarily indicated for the treatment of various bacterial infections, including respiratory tract infections (such as pneumonia, sinusitis, and bronchitis), urinary tract infections, skin and soft tissue infections, and certain gastrointestinal and sexually transmitted infections.

Levofloxacin tablets, Levolkem Tablets, Levaquin generic, fluoroquinolone antibiotic, broad-spectrum antibacterial tablets, respiratory infection treatment, UTI antibiotic, pharmaceutical exporter India, and antibacterial drug manufacturer India.

Levolkem (Levofloxacin) Tablets are manufactured under strict GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Linezolid – Lenzolieva 600 Tablets
Composition: Linezolid Tablets 600 mg
International Trade Name: Zyvox®

Lenzolieva 600 Tablets are high-quality Linezolid 600 mg tablets, a therapeutic equivalent of the internationally recognized oxazolidinone antibiotic marketed under the brand name Zyvox®. Manufactured in WHO-GMP certified facilities, Lenzolieva tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced global antibacterial and hospital infection management programs.

Linezolid is a synthetic oxazolidinone antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, making it highly effective against serious Gram-positive infections, including multi-drug resistant strains. Lenzolieva 600 Tablets are primarily indicated for the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), penicillin-resistant Streptococcus pneumoniae, hospital-acquired pneumonia, community-acquired pneumonia, skin and soft tissue infections, and other complicated Gram-positive bacterial infections.

Linezolid 600 mg tablets, Lenzolieva tablets, Zyvox generic, oxazolidinone antibiotic, MRSA infection treatment, VRE treatment tablets, hospital-acquired infection management, pharmaceutical exporter India, and antibiotic manufacturer India.

Lenzolieva 600 (Linezolid) Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for tertiary care hospitals, intensive care units, infectious disease centers, government health programs, and international pharmaceutical distributors.

RIFALIEVA 550 mg Rifaximine Tablets
Composition: Rifaximine Tablets IP 550 mg
International Trade Name: Xifaxan®

RIFALIEVA 550 Tablets are high-quality Rifaximine tablets, a therapeutic equivalent of the internationally recognized oral antibiotic marketed under the brand name Xifaxan®. Manufactured in WHO-GMP certified facilities, RIFALIEVA is supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and gastrointestinal treatment programs.

Rifaximine is a broad-spectrum, non-systemic antibiotic that inhibits bacterial RNA synthesis by binding to bacterial DNA-dependent RNA polymerase, providing effective local action in the gastrointestinal tract. RIFALIEVA 550 mg Tablets are primarily indicated for the treatment of traveler’s diarrhea caused by non-invasive Escherichia coli, prophylaxis and treatment of hepatic encephalopathy, and irritable bowel syndrome with diarrhea (IBS-D), as well as other gastrointestinal infections caused by susceptible organisms.

Rifaximine tablets 550 mg, RIFALIEVA Tablets, Xifaxan generic, non-systemic antibiotic tablets, traveler’s diarrhea therapy, IBS-D treatment, hepatic encephalopathy prevention, pharmaceutical exporter India, and antibiotic tablet manufacturer India.

RIFALIEVA 550 mg Rifaximine Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

REXIGUT-550 Rifaximine Tablets 550 mg
Composition: Rifaximine Tablets IP 550 mg
International Trade Name: Xifaxan®

REXIGUT-550 Tablets are high-quality Rifaximine tablets, a therapeutic equivalent of the internationally recognized oral antibiotic marketed under the brand name Xifaxan®. Manufactured in WHO-GMP certified facilities, REXIGUT-550 is supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and gastrointestinal treatment programs.

Rifaximine is a broad-spectrum, non-systemic antibiotic that inhibits bacterial RNA synthesis by binding to bacterial DNA-dependent RNA polymerase, providing effective local action in the gastrointestinal tract. REXIGUT-550 Tablets are primarily indicated for the treatment of traveler’s diarrhea caused by non-invasive strains of Escherichia coli, hepatic encephalopathy prophylaxis, and irritable bowel syndrome with diarrhea (IBS-D), as well as other gastrointestinal infections caused by susceptible organisms.

Rifaximine tablets 550 mg, REXIGUT-550 Tablets, Xifaxan generic, non-systemic antibiotic tablets, traveler’s diarrhea therapy, IBS-D treatment, hepatic encephalopathy prevention, pharmaceutical exporter India, and antibiotic tablet manufacturer India.

REXIGUT-550 Rifaximine 550 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Artesunate Tablets – Ridsunate
Composition: Artesunate Tablets IP
International Trade Name: Artesunate

Ridsunate is a high-quality Artesunate Tablet, manufactured in WHO-GMP certified facilities and supplied by trusted pharmaceutical manufacturers and exporters from India to support global malaria control and antimalarial treatment programs.

Artesunate is a fast-acting artemisinin derivative that works by generating reactive oxygen species within the malaria parasite, leading to rapid parasite clearance. Ridsunate Artesunate Tablets are primarily indicated for the treatment of uncomplicated and severe malaria caused by Plasmodium falciparum and Plasmodium vivax, either as monotherapy where appropriate or in combination regimens as part of artemisinin-based combination therapy (ACT), in accordance with national and WHO treatment guidelines.

Artesunate tablets, Ridsunate Tablets, antimalarial medicine, artemisinin derivative, malaria treatment tablets, Plasmodium falciparum therapy, pharmaceutical exporter India, and antimalarial tablet manufacturer India.

Ridsunate Artesunate Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, moisture-protected, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, government malaria control programs, NGOs, and international pharmaceutical distributors.

Ambisome Liposomal Amphotericin B for Injection 50 mg
Composition: Liposomal Amphotericin B Injection IP 50 mg
International Trade Name: Ambisome®

Ambisome 50 mg Injection is a high-quality Liposomal Amphotericin B, a therapeutic equivalent of the internationally recognized antifungal marketed under the brand name Ambisome®. Manufactured in WHO-GMP certified facilities, Ambisome Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced global antifungal treatment programs.

Liposomal Amphotericin B is a broad-spectrum antifungal agent formulated in a lipid-based delivery system that enhances tissue targeting while reducing nephrotoxicity compared to conventional amphotericin B. Ambisome 50 mg Injection is primarily indicated for the treatment of severe systemic fungal infections, including invasive candidiasis, cryptococcal meningitis, mucormycosis, and other life-threatening mycoses, as well as visceral leishmaniasis in endemic regions.

Liposomal Amphotericin B injection 50 mg, Ambisome Injection, Ambisome generic, systemic antifungal therapy, invasive fungal infection treatment, mucormycosis therapy, ICU antifungal injection, pharmaceutical exporter India, and injectable antifungal manufacturer India.

Ambisome 50 mg Liposomal Amphotericin B Injection is manufactured under stringent GMP and sterile biologics quality standards to ensure consistent efficacy, safety, and stability. The injection is supplied in sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for tertiary care hospitals, intensive care units (ICUs), government healthcare programs, and international pharmaceutical distributors.

Neosurf 3 ml Bovine Lipid Extract Surfactant Suspension
Composition: Bovine Lipid Extract Surfactant Suspension
International Trade Name: Survanta® (Comparable Reference)

Neosurf 3 ml is a high-quality Bovine Lipid Extract Surfactant Suspension, a therapeutic equivalent of internationally used natural pulmonary surfactant preparations such as Survanta®. Manufactured in WHO-GMP certified facilities, Neosurf is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced neonatal and critical care respiratory treatment programs worldwide.

Bovine lipid extract surfactant is a natural pulmonary surfactant that reduces surface tension within the alveoli, improving lung compliance and oxygenation in premature infants. Neosurf 3 ml Suspension is primarily indicated for the prevention and treatment of Neonatal Respiratory Distress Syndrome (NRDS/RDS) in preterm infants with surfactant deficiency, helping to reduce respiratory failure, ventilator dependence, and associated complications.

Bovine lipid extract surfactant, Neosurf Suspension, natural lung surfactant injection, neonatal RDS treatment, pulmonary surfactant therapy, NICU respiratory care medicine, neonatal critical care injection, pharmaceutical exporter India, and neonatal drug manufacturer India.

Neosurf 3 ml Bovine Lipid Extract Surfactant Suspension is manufactured under stringent GMP and sterile biologics quality standards to ensure consistent efficacy, safety, and stability. The suspension is supplied in sterile, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for NICUs, tertiary care hospitals, government neonatal programs, and international pharmaceutical distributors.

Neosurf 3 ml – Bovine Lipid Extract Surfactant Suspension
Composition: Bovine Lipid Extract Surfactant Suspension
International Trade Name: Survanta® (Comparable)

Neosurf 3 ml is a high-quality Bovine Lipid Extract Surfactant (BLES) suspension, therapeutically comparable to internationally recognized natural pulmonary surfactant preparations such as Survanta®. Manufactured in WHO-GMP certified facilities, Neosurf is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced neonatal and critical care respiratory treatment programs worldwide.

Bovine lipid extract surfactant replaces deficient or inactivated endogenous pulmonary surfactant in premature and term neonates, reducing alveolar surface tension and improving lung compliance and oxygenation. Neosurf 3 ml Suspension is primarily indicated for the prevention and treatment of Neonatal Respiratory Distress Syndrome (NRDS) in preterm infants, as well as for the management of acute respiratory failure in neonates requiring mechanical ventilation.

Bovine lipid extract surfactant, Neosurf 3 ml, natural surfactant therapy, neonatal RDS treatment, pulmonary surfactant suspension, NICU respiratory care, neonatal critical care injection, pharmaceutical exporter India, and neonatal medicine manufacturer India.

Neosurf 3 ml (Bovine Lipid Extract Surfactant Suspension) is manufactured under stringent GMP and sterile biologics quality standards to ensure consistent efficacy, safety, and stability. The suspension is supplied in secure, cold-chain–compliant, export-grade packaging with complete regulatory documentation, making it suitable for neonatal intensive care units (NICUs), tertiary care hospitals, government maternal–child health programs, and international pharmaceutical distributors.

Lizoforce Linezolid Injection
Composition: Linezolid Injection
International Trade Name: Zyvox®

Lizoforce is a high-quality Linezolid Injection, a therapeutic equivalent of the internationally recognized oxazolidinone antibiotic marketed under the brand name Zyvox®. Manufactured in WHO-GMP certified facilities, Lizoforce Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced global anti-infective and hospital-based treatment programs.

Linezolid is a potent, synthetic oxazolidinone antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, making it highly effective against serious Gram-positive bacterial infections. Lizoforce Linezolid Injection is primarily indicated for the treatment of complicated and uncomplicated skin and soft tissue infections, hospital-acquired and community-acquired pneumonia, bacteremia, and infections caused by multidrug-resistant organisms such as MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococcus).

Linezolid injection, Lizoforce Injection, Zyvox generic, oxazolidinone antibiotic, MRSA treatment injection, VRE infection therapy, hospital antibiotic injection, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

Lizoforce Linezolid Injection is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent efficacy, safety, and stability. The injection is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for intensive care units (ICUs), tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Doxyt (Doxycycline Hyclate) Tablets
Composition: Doxycycline Hyclate Tablets
International Trade Name: Vibramycin®

Doxyt Tablets are high-quality Doxycycline Hyclate tablets, a therapeutic equivalent of the internationally recognized tetracycline-class antibiotic marketed under the brand name Vibramycin®. Manufactured in WHO-GMP certified facilities, Doxyt is supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and anti-infective treatment programs.

Doxycycline hyclate is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Doxyt Tablets are primarily indicated for the treatment of a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, sexually transmitted infections (such as chlamydia), acne vulgaris, rickettsial infections, malaria prophylaxis, and certain zoonotic infections caused by susceptible organisms.

Doxycycline hyclate tablets, Doxyt Tablets, Vibramycin generic, tetracycline antibiotic tablets, acne treatment antibiotic, STI treatment tablets, respiratory infection therapy, pharmaceutical exporter India, and antibiotic tablet manufacturer India.

Doxyt (Doxycycline Hyclate) Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Vorier 200 mg Voriconazole Tablets
Composition: Voriconazole Tablets IP 200 mg
International Trade Name: Vfend®

Vorier 200 mg Tablets are high-quality Voriconazole tablets, a therapeutic equivalent of the internationally recognized triazole antifungal marketed under the brand name Vfend®. Manufactured in WHO-GMP certified facilities, Vorier Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antifungal and hospital-based treatment programs.

Voriconazole is a broad-spectrum triazole antifungal that inhibits the fungal enzyme lanosterol 14-α-demethylase, disrupting ergosterol synthesis and compromising the fungal cell membrane. Vorier 200 mg Tablets are primarily indicated for the treatment of serious systemic fungal infections, including invasive aspergillosis, candidemia, esophageal candidiasis, and infections caused by Scedosporium and Fusarium species, particularly in immunocompromised patients.

Voriconazole tablets 200 mg, Vorier Tablets, Vfend generic, systemic antifungal therapy, invasive fungal infection treatment, ICU antifungal tablets, hospital antifungal therapy, pharmaceutical exporter India, and antifungal tablet manufacturer India.

Vorier 200 mg Voriconazole Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, tertiary care centers, government healthcare programs, and international pharmaceutical distributors.

Elores 3.0 g (Ceftriaxone, Disodium Edetate & Sulbactam) Powder for Solution for Infusion
Composition: Ceftriaxone Sodium IP + Sulbactam Sodium IP + Disodium Edetate IP – 3.0 g per vial
International Trade Name: Unasyn® / Ceftriaxone-Sulbactam Combinations

Elores 3.0 g Powder for Solution for Infusion is a high-quality Ceftriaxone-Sulbactam combination with Disodium Edetate, a therapeutic equivalent of internationally recognized broad-spectrum β-lactam/β-lactamase inhibitor antibiotics. Manufactured in WHO-GMP certified facilities, Elores is supplied by trusted pharmaceutical manufacturers and exporters from India to support global hospital-based antibacterial and critical care treatment programs.

Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Sulbactam is a β-lactamase inhibitor that enhances the spectrum of Ceftriaxone against β-lactamase producing bacteria. Disodium Edetate acts as a chelating agent to stabilize the formulation. Elores 3.0 g Powder for Solution for Infusion is primarily indicated for the treatment of moderate to severe bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, bone and joint infections, and other infections caused by susceptible Gram-positive and Gram-negative organisms.

Ceftriaxone-Sulbactam injection 3.0 g, Elores Powder for Solution for Infusion, Unasyn generic, β-lactam/β-lactamase inhibitor combination, severe bacterial infection therapy, ICU antibacterial injection, hospital antibiotic therapy, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

Elores 3.0 g Powder for Solution for Infusion is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent potency, safety, and stability. The injection is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for tertiary care hospitals, intensive care units (ICUs), government healthcare programs, and international pharmaceutical distributors.

Coly-Monas Colistimethate Sodium for Injection IP 1 MIU
Composition: Colistimethate Sodium Injection IP 1 MIU
International Trade Name: Coly-Mycin® 

Coly-Monas 1 MIU Injection is a high-quality Colistimethate Sodium injection, a therapeutic equivalent of the internationally recognized polymyxin-class antibiotic marketed under the brand name Coly-Mycin® M. Manufactured in WHO-GMP certified facilities, Coly-Monas Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced hospital-based and critical care antibacterial treatment programs.

Colistimethate Sodium is a polypeptide antibiotic that disrupts bacterial cell membrane integrity, exhibiting potent activity against multidrug-resistant Gram-negative organisms. Coly-Monas 1 MIU Injection is primarily indicated for the treatment of severe infections caused by Pseudomonas aeruginosa, Acinetobacter species, Klebsiella pneumoniae, and other multidrug-resistant Gram-negative bacteria, including ventilator-associated pneumonia, sepsis, urinary tract infections, and complicated intra-abdominal infections.

Colistimethate Sodium injection 1 MIU, Coly-Monas Injection, Coly-Mycin M generic, multidrug-resistant Gram-negative infection therapy, ICU antibiotic injection, hospital antibacterial therapy, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

Coly-Monas 1 MIU Colistimethate Sodium Injection is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent potency, safety, and stability. The injection is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for intensive care units (ICUs), tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Doxt-SL – Doxycycline and Lactic Acid Bacillus Tablets
Composition: Doxycycline Hyclate Tablets IP 100 mg + Lactic Acid Bacillus Capsules IP
International Trade Name: Vibramycin + Probiotic

Doxt-SL is a high-quality Doxycycline and Lactic Acid Bacillus combination Tablet, manufactured in WHO-GMP certified facilities and supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and gut health treatment programs.

Doxycycline is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, effectively treating a wide range of Gram-positive and Gram-negative bacterial infections. Lactic Acid Bacillus is a probiotic that restores healthy gut flora, prevents antibiotic-associated diarrhea, and supports gastrointestinal balance during and after antibiotic therapy.

Doxt-SL Tablets are primarily indicated for respiratory tract infections, urinary tract infections, skin and soft tissue infections, sexually transmitted infections, and gastrointestinal protection during prolonged antibiotic therapy.

Doxycycline and Lactic Acid Bacillus tablets, Doxt-SL Tablets, Vibramycin + Probiotic generic, broad-spectrum antibiotic with probiotic, antibiotic-associated diarrhea prevention, oral antibacterial therapy, pharmaceutical exporter India, and combination tablet manufacturer India.

Doxt-SL Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Urivron Nitrofurantoin 100 mg Tablets
Composition: Nitrofurantoin Tablets IP 100 mg
International Trade Name: Macrobid®

Urivron 100 is a high-quality Nitrofurantoin 100 mg Tablet, a therapeutic equivalent of the internationally recognized urinary antiseptic marketed under the brand name Macrobid®. Manufactured in WHO-GMP certified facilities, Urivron Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global urology and urinary tract infection (UTI) treatment programs.

Nitrofurantoin is a urinary antibacterial agent that works by inhibiting bacterial enzymes involved in carbohydrate metabolism and cell wall synthesis, making it highly effective against common uropathogens. Urivron Nitrofurantoin 100 mg Tablets are primarily indicated for the treatment and prophylaxis of uncomplicated urinary tract infections caused by susceptible organisms, including Escherichia coli, Enterococcus species, Staphylococcus saprophyticus, and Klebsiella species.

Nitrofurantoin tablets 100 mg, Urivron Tablets, Macrobid generic, UTI antibiotic tablets, urinary antiseptic, uncomplicated UTI treatment, pharmaceutical exporter India, and antibacterial tablet manufacturer India.

Urivron Nitrofurantoin 100 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

CYOMIN 50 – Minocycline HCl Capsules
Composition: Minocycline Hydrochloride Capsules IP 50 mg
International Trade Name: Minocin®

CYOMIN 50 is a high-quality Minocycline Hydrochloride 50 mg Capsule, a therapeutic equivalent of the internationally recognized tetracycline-class antibiotic marketed under the brand name Minocin®. Manufactured in WHO-GMP certified facilities, CYOMIN Capsules are supplied by trusted pharmaceutical manufacturers and exporters from India to support global oral antibacterial treatment programs.

Minocycline is a broad-spectrum, semi-synthetic tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. CYOMIN 50 Capsules are primarily indicated for the treatment of acne vulgaris, respiratory tract infections, skin and soft tissue infections, urinary tract infections, sexually transmitted infections, and other infections caused by susceptible Gram-positive and Gram-negative organisms.

Minocycline capsules 50 mg, CYOMIN 50 Capsule, Minocin generic, tetracycline antibiotic, acne treatment capsules, broad-spectrum antibacterial therapy, oral antibiotic exporter India, and pharmaceutical capsule manufacturer India.

CYOMIN 50 Minocycline HCl Capsules are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, dermatology clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Azorit 250 – Azithromycin 250 mg Tablets
Composition: Azithromycin Tablets IP 250 mg
International Trade Name: Zithromax®

Azorit 250 is a high-quality Azithromycin 250 mg Tablet, a therapeutic equivalent of the internationally recognized macrolide antibiotic marketed under the brand name Zithromax®. Manufactured in WHO-GMP certified facilities, Azorit Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial treatment programs.

Azithromycin is a broad-spectrum macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, making it effective against a wide range of Gram-positive and Gram-negative pathogens. Azorit 250 Tablets are primarily indicated for the treatment of respiratory tract infections, skin and soft tissue infections, sexually transmitted infections, otitis media, pharyngitis, and community-acquired pneumonia caused by susceptible organisms.

Azithromycin tablets 250 mg, Azorit 250 Tablet, Zithromax generic, macrolide antibiotic, respiratory and skin infection therapy, oral antibacterial therapy, pharmaceutical exporter India, and tablet manufacturer India.

Azorit 250 Azithromycin Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

AZORIT 500 Azithromycin Tablets
Composition: Azithromycin Tablets IP 500 mg
International Trade Name: Zithromax®

AZORIT 500 Tablets are high-quality Azithromycin tablets, a therapeutic equivalent of the internationally recognized macrolide antibiotic marketed under the brand name Zithromax®. Manufactured in WHO-GMP certified facilities, AZORIT Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and community/hospital-based treatment programs.

Azithromycin is a broad-spectrum macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, providing potent activity against a wide range of Gram-positive and Gram-negative organisms. AZORIT 500 Tablets are primarily indicated for the treatment of respiratory tract infections (including pneumonia, bronchitis, and sinusitis), skin and soft tissue infections, sexually transmitted infections (such as chlamydia), and other bacterial infections caused by susceptible organisms.

Azithromycin tablets 500 mg, AZORIT Tablets, Zithromax generic, macrolide antibiotic tablets, respiratory infection treatment, skin infection therapy, STI treatment tablets, pharmaceutical exporter India, and antibiotic tablet manufacturer India.

AZORIT 500 Azithromycin Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Garivid OZ – Ofloxacin & Ornidazole Tablets
Composition: Ofloxacin Tablets IP + Ornidazole Tablets IP
International Trade Name: Floxazole®

Garivid OZ is a high-quality Ofloxacin and Ornidazole combination Tablet, manufactured in WHO-GMP certified facilities and supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and antiprotozoal treatment programs.

Ofloxacin is a broad-spectrum fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, providing potent activity against Gram-positive and Gram-negative bacteria. Ornidazole is an antiprotozoal and antibacterial agent effective against anaerobic bacteria and protozoal infections. Garivid OZ Tablets are primarily indicated for the treatment of gastrointestinal infections, dysentery, amoebiasis, giardiasis, traveler's diarrhea, bacterial diarrhea, and mixed anaerobic infections.

Ofloxacin and Ornidazole tablets, Garivid OZ Tablets, Floxazole generic, fluoroquinolone-antiprotozoal combination, gastrointestinal infection therapy, antibacterial and antiprotozoal tablets, pharmaceutical exporter India, and combination tablet manufacturer India.

Garivid OZ Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Ridprim DS – Trimethoprim & Sulfamethoxazole Tablets
Composition: Trimethoprim + Sulfamethoxazole Tablets (Double Strength)
International Trade Name: Co-trimoxazole®

Ridprim DS Tablets are high-quality Trimethoprim and Sulfamethoxazole combination tablets, a therapeutic equivalent of the internationally recognized antibacterial combination marketed under the brand name Co-trimoxazole®. Manufactured in WHO-GMP certified facilities, Ridprim DS is supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and infectious disease treatment programs.

Trimethoprim and Sulfamethoxazole work synergistically by sequentially inhibiting bacterial folate synthesis, resulting in enhanced bactericidal activity against a wide range of Gram-positive and Gram-negative organisms. Ridprim DS Tablets are primarily indicated for the treatment of urinary tract infections (UTIs), respiratory tract infections, gastrointestinal infections, skin and soft tissue infections, Pneumocystis jirovecii pneumonia (PCP), toxoplasmosis, and certain opportunistic infections in immunocompromised patients.

Trimethoprim sulfamethoxazole tablets, Ridprim DS tablets, co-trimoxazole double strength, broad-spectrum antibacterial tablets, UTI infection treatment, PCP pneumonia treatment, antimicrobial combination tablets, pharmaceutical exporter India, and antibiotic manufacturer India.

Ridprim DS (Trimethoprim & Sulfamethoxazole) Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Vancocin (Vancomycin) – Vansafe CP 1 g
Composition: Vancomycin Hydrochloride Injection IP 1 g
International Trade Name: Vancocin®

Vansafe CP 1 g is a high-quality Vancomycin Hydrochloride Injection, a therapeutic equivalent of the internationally recognized glycopeptide antibiotic marketed under the brand name Vancocin®. Manufactured in WHO-GMP certified facilities, Vansafe CP Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support global hospital-based and critical care anti-infective treatment programs.

Vancomycin is a potent glycopeptide antibiotic that inhibits bacterial cell wall synthesis and is highly effective against serious Gram-positive bacterial infections. Vansafe CP 1 g Injection is primarily indicated for the treatment of severe and life-threatening infections caused by susceptible organisms, including MRSA (Methicillin-resistant Staphylococcus aureus), penicillin-resistant Streptococcus, Enterococcus species, septicemia, endocarditis, bone and joint infections, skin and soft tissue infections, and hospital-acquired pneumonia.

Vancomycin injection 1 g, Vansafe CP Injection, Vancocin generic, glycopeptide antibiotic, MRSA treatment injection, severe Gram-positive infection therapy, ICU antibiotic injection, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

Vansafe CP 1 g Vancomycin Injection is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent potency, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for intensive care units (ICUs), tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Vancocin (Vancomycin Hydrochloride) – Vanking 500
Composition: Vancomycin Hydrochloride Injection 500 mg
International Trade Name: Vancocin®

Vanking 500 is a high-quality Vancomycin Hydrochloride 500 mg injection, a therapeutic equivalent of the internationally recognized glycopeptide antibiotic marketed under the brand name Vancocin®. Manufactured in WHO-GMP certified facilities, Vanking 500 Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced hospital-based and critical-care antibacterial treatment programs worldwide.

Vancomycin Hydrochloride is a potent glycopeptide antibiotic that inhibits bacterial cell wall synthesis and is particularly effective against serious Gram-positive infections, including multidrug-resistant organisms. Vanking 500 Injection is primarily indicated for the treatment of severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae, Enterococcus species, and other susceptible Gram-positive bacteria. It is commonly used in cases of septicemia, endocarditis, pneumonia, bone and joint infections, skin and soft tissue infections, and hospital-acquired infections.

Vancomycin hydrochloride injection 500 mg, Vanking 500 injection, Vancocin generic, glycopeptide antibiotic, MRSA infection treatment, hospital-acquired infection management, critical care antibiotic injection, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

Vanking 500 (Vancomycin Hydrochloride) Injection is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent potency, safety, and therapeutic efficacy. The injection is supplied in secure, export-grade, cold-chain–compliant packaging with complete regulatory documentation, making it suitable for tertiary care hospitals, intensive care units (ICUs), infectious disease centers, government healthcare programs, and international pharmaceutical distributors.

Vancocin (Vancomycin) – Vansafe CP 500 mg
Composition: Vancomycin Hydrochloride Injection IP 500 mg
International Trade Name: Vancocin®

Vansafe CP 500 mg is a high-quality Vancomycin Hydrochloride Injection, a therapeutic equivalent of the internationally recognized glycopeptide antibiotic marketed under the brand name Vancocin®. Manufactured in WHO-GMP certified facilities, Vansafe CP Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support global hospital-based and critical care anti-infective treatment programs.

Vancomycin is a potent glycopeptide antibiotic that inhibits bacterial cell wall synthesis and is highly effective against serious Gram-positive bacterial infections. Vansafe CP 500 mg Injection is primarily indicated for the treatment of severe and life-threatening infections caused by susceptible organisms, including MRSA (Methicillin-resistant Staphylococcus aureus), penicillin-resistant Streptococcus, Enterococcus species, septicemia, endocarditis, bone and joint infections, skin and soft tissue infections, and hospital-acquired pneumonia.

Vancomycin injection 500 mg, Vansafe CP Injection, Vancocin generic, glycopeptide antibiotic, MRSA treatment injection, severe Gram-positive infection therapy, ICU antibiotic injection, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

Vansafe CP 500 mg Vancomycin Injection is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent potency, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for intensive care units (ICUs), tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Cefepime – Novapime Injection
Composition: Cefepime Hydrochloride Injection
International Trade Name: Maxipime®

Novapime Injection is a high-quality Cefepime Hydrochloride Injection, a therapeutic equivalent of the internationally recognized fourth-generation cephalosporin antibiotic marketed under the brand name Maxipime®. Manufactured in WHO-GMP certified facilities, Novapime Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced hospital-based and critical care antibacterial treatment programs worldwide.

Cefepime is a broad-spectrum, fourth-generation cephalosporin antibiotic with strong activity against both Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. Novapime Injection is primarily indicated for the treatment of severe and life-threatening infections such as hospital-acquired and community-acquired pneumonia, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, febrile neutropenia, and septicemia caused by susceptible organisms.

Cefepime injection, Novapime Injection, Maxipime generic, fourth-generation cephalosporin, Pseudomonas infection treatment, ICU antibiotic injection, hospital antibacterial therapy, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

Novapime (Cefepime) Injection is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent potency, safety, and stability. The injection is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for intensive care units (ICUs), tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Aldol Albendazole 400 mg Tablets
Composition: Albendazole Tablets IP 400 mg
International Trade Name: Albenza®

Aldol 400 is a high-quality Albendazole 400 mg Tablet, a therapeutic equivalent of the internationally recognized broad-spectrum anthelmintic marketed under the brand name Albenza®. Manufactured in WHO-GMP certified facilities, Aldol Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global deworming and antiparasitic treatment programs.

Albendazole is a benzimidazole class anthelmintic that works by inhibiting microtubule synthesis in parasites, leading to impaired glucose uptake and parasite death. Aldol Albendazole 400 mg Tablets are primarily indicated for the treatment of intestinal and systemic parasitic infections, including ascariasis, hookworm infection, enterobiasis (pinworm), trichuriasis (whipworm), strongyloidiasis, hydatid disease (echinococcosis), and neurocysticercosis.

Albendazole tablets 400 mg, Aldol 400 Tablet, Albenza generic, anthelmintic tablets, deworming medicine, antiparasitic treatment, pharmaceutical exporter India, and antiparasitic tablet manufacturer India.

Aldol Albendazole 400 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government deworming programs, NGOs, and international pharmaceutical distributors.

Viktrim D.S. – Trimethoprim & Sulphamethoxazole Tablets
Composition: Trimethoprim 160 mg + Sulphamethoxazole 800 mg Tablets IP
International Trade Name: Bactrim®

Viktrim D.S. is a high-quality Trimethoprim and Sulphamethoxazole combination Tablet, a therapeutic equivalent of the internationally recognized co-trimoxazole antibiotic marketed under the brand name Bactrim®. Manufactured in WHO-GMP certified facilities, Viktrim D.S. Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial treatment programs.

Trimethoprim-Sulphamethoxazole is a synergistic combination that inhibits sequential steps in bacterial folate synthesis, providing broad-spectrum bactericidal activity. Viktrim D.S. Tablets are primarily indicated for the treatment of urinary tract infections, respiratory tract infections, gastrointestinal infections, acute otitis media, pneumonia (including Pneumocystis jirovecii pneumonia), and other infections caused by susceptible Gram-positive and Gram-negative bacteria.

Trimethoprim-Sulphamethoxazole tablets, Viktrim D.S. Tablets, Bactrim generic, co-trimoxazole antibiotic, urinary tract infection therapy, respiratory and gastrointestinal infection treatment, pharmaceutical exporter India, and combination tablet manufacturer India.

Viktrim D.S. Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Vorifend 200 – Voriconazole 200 mg Tablets
Composition: Voriconazole Tablets IP 200 mg
International Trade Name: Vfend®

Vorifend 200 is a high-quality Voriconazole 200 mg Tablet, a therapeutic equivalent of the internationally recognized triazole antifungal marketed under the brand name Vfend®. Manufactured in WHO-GMP certified facilities, Vorifend Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antifungal treatment programs.

Voriconazole is a broad-spectrum triazole antifungal that inhibits fungal cytochrome P450-dependent 14α-sterol demethylase, disrupting ergosterol synthesis and fungal cell membrane formation. Vorifend 200 Tablets are primarily indicated for the treatment of serious fungal infections, including invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and infections caused by Scedosporium and Fusarium species, particularly in immunocompromised patients.

Voriconazole tablets 200 mg, Vorifend 200 Tablet, Vfend generic, triazole antifungal, invasive fungal infection therapy, hospital antifungal treatment, pharmaceutical exporter India, and antifungal tablet manufacturer India.

Vorifend 200 Voriconazole Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, tertiary care centers, government healthcare programs, and international pharmaceutical distributors.

VORILIEVA 200 mg Voriconazole Tablets
Composition: Voriconazole Tablets IP 200 mg
International Trade Name: Vfend®

VORILIEVA 200 mg Tablets are high-quality Voriconazole tablets, a therapeutic equivalent of the internationally recognized triazole antifungal marketed under the brand name Vfend®. Manufactured in WHO-GMP certified facilities, VORILIEVA Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antifungal and hospital-based treatment programs.

Voriconazole is a broad-spectrum triazole antifungal agent that inhibits fungal cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, essential for ergosterol synthesis, resulting in disruption of fungal cell membrane formation. VORILIEVA 200 mg Tablets are primarily indicated for the treatment of invasive fungal infections, including invasive aspergillosis, candidemia, esophageal candidiasis, serious fungal infections caused by Scedosporium and Fusarium species, and other severe systemic mycoses in immunocompromised patients.

Voriconazole tablets 200 mg, VORILIEVA Tablets, Vfend generic, systemic antifungal therapy, invasive fungal infection treatment, ICU antifungal tablets, hospital antifungal therapy, pharmaceutical exporter India, and antifungal tablet manufacturer India.

VORILIEVA 200 mg Voriconazole Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent efficacy, safety, and stability. The tablets are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, tertiary care centers, government healthcare programs, and international pharmaceutical distributors.

Isuvaz 100 – Isavuconazole 100 mg Capsules
Composition: Isavuconazole Capsules IP 100 mg
International Trade Name: Cresemba®

Isuvaz 100 is a high-quality Isavuconazole 100 mg Capsule, a therapeutic equivalent of the internationally recognized broad-spectrum triazole antifungal marketed under the brand name Cresemba®. Manufactured in WHO-GMP certified facilities, Isuvaz Capsules are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antifungal treatment programs, particularly for invasive fungal infections.

Isavuconazole is a triazole antifungal that inhibits fungal lanosterol 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane formation. Isuvaz 100 Capsules are primarily indicated for the treatment of serious fungal infections, including invasive aspergillosis and invasive mucormycosis, especially in immunocompromised patients or those intolerant to other antifungal therapies.

Isavuconazole capsules 100 mg, Isuvaz 100 Capsule, Cresemba generic, triazole antifungal, invasive fungal infection therapy, hospital antifungal capsule, pharmaceutical exporter India, and antifungal capsule manufacturer India.

Isuvaz 100 Isavuconazole Capsules are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, tertiary care centers, government healthcare programs, and international pharmaceutical distributors.

T-Planin 400 – Teicoplanin 400 mg Injection
Composition: Teicoplanin Injection IP 400 mg
International Trade Name: Targocid®

T-Planin 400 is a high-quality Teicoplanin 400 mg Injection, a therapeutic equivalent of the internationally recognized glycopeptide antibiotic marketed under the brand name Targocid®. Manufactured in WHO-GMP certified facilities, T-Planin Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support global hospital-based and critical care anti-infective treatment programs.

Teicoplanin is a potent glycopeptide antibiotic that inhibits bacterial cell wall synthesis and is highly effective against serious Gram-positive bacterial infections. T-Planin 400 Injection is primarily indicated for the treatment of severe infections caused by susceptible organisms, including MRSA (Methicillin-resistant Staphylococcus aureus), Staphylococcus epidermidis, penicillin-resistant Streptococcus, and Enterococcus species. It is suitable for treating bacteremia, endocarditis, bone and joint infections, skin and soft tissue infections, and hospital-acquired pneumonia.

Teicoplanin injection 400 mg, T-Planin 400 Injection, Targocid generic, glycopeptide antibiotic, MRSA treatment injection, severe Gram-positive infection therapy, ICU antibiotic injection, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

T-Planin 400 Teicoplanin Injection is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent potency, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for intensive care units (ICUs), tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Crabmin Minocycline Injection
Composition: Minocycline Hydrochloride Injection IP
International Trade Name: Dynacin®

Crabmin Injection is a high-quality Minocycline Hydrochloride Injection, a therapeutic equivalent of the internationally recognized tetracycline-class antibiotic marketed under the brand name Dynacin®. Manufactured in WHO-GMP certified facilities, Crabmin Injection is supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and hospital-based treatment programs.

Minocycline is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, providing potent activity against a wide range of Gram-positive and Gram-negative organisms. Crabmin Injection is primarily indicated for the treatment of severe systemic bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, acne vulgaris, rickettsial infections, and other infections caused by susceptible microorganisms, particularly in patients unable to take oral antibiotics.

Minocycline injection, Crabmin Injection, Dynacin generic, tetracycline antibiotic injection, severe bacterial infection therapy, ICU antibacterial injection, hospital antibiotic therapy, pharmaceutical exporter India, and injectable antibiotic manufacturer India.

Crabmin Minocycline Injection is manufactured under stringent GMP and sterile injectable quality standards to ensure consistent potency, safety, and therapeutic efficacy. The injection is supplied in sterile, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, tertiary care centers, intensive care units (ICUs), government healthcare programs, and international pharmaceutical distributors.

DOXYT Doxycycline Hyclate Tablets USP
Composition: Doxycycline Hyclate Tablets USP
International Trade Name: Vibramycin®

DOXYT Tablets are high-quality Doxycycline Hyclate tablets, a therapeutic equivalent of the internationally recognized tetracycline-class antibiotic marketed under the brand name Vibramycin®. Manufactured in WHO-GMP certified facilities, DOXYT is supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and anti-infective treatment programs.

Doxycycline Hyclate is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, providing potent activity against Gram-positive, Gram-negative, and atypical organisms. DOXYT Tablets are primarily indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, sexually transmitted infections (including chlamydia), rickettsial infections, acne vulgaris, and other bacterial infections caused by susceptible organisms.

Doxycycline Hyclate tablets USP, DOXYT Tablets, Vibramycin generic, tetracycline antibiotic tablets, respiratory infection treatment, STI treatment tablets, acne therapy, pharmaceutical exporter India, and antibiotic tablet manufacturer India.

DOXYT Doxycycline Hyclate Tablets USP are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Atorstin – Atorvastatin Tablets
Composition: Atorvastatin Tablets IP (Available strengths: 10 mg, 20 mg, 40 mg, 80 mg)
International Trade Name: Lipitor®

Atorstin is a high-quality Atorvastatin Tablet, a therapeutic equivalent of the internationally recognized HMG-CoA reductase inhibitor marketed under the brand name Lipitor®. Manufactured in WHO-GMP certified facilities, Atorstin Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global cardiovascular health and cholesterol management programs.

Atorvastatin is a potent statin that works by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, effectively lowering LDL cholesterol, total cholesterol, and triglycerides while increasing HDL cholesterol. Atorstin Tablets are primarily indicated for the treatment of hypercholesterolemia, mixed dyslipidemia, familial hypercholesterolemia, and for the prevention of cardiovascular disease in high-risk patients.

Atorvastatin tablets, Atorstin Tablets, Lipitor generic, statin therapy, cholesterol-lowering tablets, cardiovascular disease prevention, pharmaceutical exporter India, and tablet manufacturer India.

Atorstin Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government health programs, and international pharmaceutical distributors.

Zocef – Cefuroxime Tablets
Composition: Cefuroxime Axetil Tablets IP (Available strengths: 250 mg, 500 mg)
International Trade Name: Ceftin®

Zocef is a high-quality Cefuroxime Axetil Tablet, a therapeutic equivalent of the internationally recognized second-generation cephalosporin antibiotic marketed under the brand name Ceftin®. Manufactured in WHO-GMP certified facilities, Zocef Tablets are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial treatment programs.

Cefuroxime is a broad-spectrum cephalosporin antibiotic that inhibits bacterial cell wall synthesis, making it highly effective against both Gram-positive and Gram-negative pathogens. Zocef Tablets are primarily indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, otitis media, tonsillitis, pharyngitis, and other infections caused by susceptible organisms.

Cefuroxime tablets, Zocef Tablets, Ceftin generic, second-generation cephalosporin, broad-spectrum antibacterial therapy, oral antibiotic treatment, pharmaceutical exporter India, and tablet manufacturer India.

Zocef Cefuroxime Tablets are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

CYOMIN 100 Minocycline HCl Capsules
Composition: Minocycline Hydrochloride Capsules IP 100 mg
International Trade Name: Dynacin®

CYOMIN 100 Capsules are high-quality Minocycline Hydrochloride capsules, a therapeutic equivalent of the internationally recognized tetracycline-class antibiotic marketed under the brand name Dynacin®. Manufactured in WHO-GMP certified facilities, CYOMIN Capsules are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and hospital/community-based treatment programs.

Minocycline HCl is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, providing potent activity against Gram-positive, Gram-negative, and atypical bacteria. CYOMIN 100 Capsules are primarily indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, acne vulgaris, rickettsial infections, sexually transmitted infections, and other bacterial infections caused by susceptible organisms.

Minocycline HCl capsules 100 mg, CYOMIN 100 Capsules, Dynacin generic, tetracycline antibiotic capsules, acne treatment capsules, respiratory infection therapy, STI treatment capsules, pharmaceutical exporter India, and antibiotic capsule manufacturer India.

CYOMIN 100 Minocycline HCl Capsules are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The capsules are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Cephalexin Capsules 500 mg
Composition: Cephalexin Capsules IP 500 mg
International Trade Name: Keflex®

Cephalexin Capsules 500 mg are high-quality first-generation cephalosporin antibiotic capsules, a therapeutic equivalent of the internationally recognized brand Keflex®. Manufactured in WHO-GMP certified facilities, Cephalexin Capsules are supplied by trusted pharmaceutical manufacturers and exporters from India to support global antibacterial and primary healthcare treatment programs.

Cephalexin is a broad-spectrum beta-lactam antibiotic that works by inhibiting bacterial cell wall synthesis, making it effective against a wide range of Gram-positive and selected Gram-negative organisms. Cephalexin Capsules 500 mg are primarily indicated for the treatment of respiratory tract infections, skin and soft tissue infections, urinary tract infections, bone infections, and other bacterial infections caused by susceptible microorganisms.

Cephalexin capsules 500 mg, Keflex generic, cephalosporin antibiotic capsules, skin infection treatment, UTI antibiotic capsules, respiratory infection therapy, pharmaceutical exporter India, and antibiotic capsule manufacturer India.

Cephalexin Capsules 500 mg are manufactured under stringent GMP and pharmaceutical quality standards to ensure consistent potency, safety, and therapeutic efficacy. The capsules are supplied in secure, export-grade blister or bottle packaging with complete regulatory documentation, making them suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.